In the world of type 1 diabetes organizations, T1D Exchange is a relatively new face. We began 5 years ago as a vision to accelerate research to improve type 1 outcomes and we've been working towards that vision ever since.
In recent months, it became clear to me that our vision is quickly becoming reality.
Want to know more? Watch a mini-documentary film about T1D Exchange and learn how, together with you, T1D Exchange is
truly transforming T1D research.
Have a great day!
Dana A. Ball
Executive Director & Founder
Using data from the Clinic Registry, T1D Exchange conducted a sweeping analysis assessing the current state of diabetes treatment in the U.S. Our researchers conclude that there remains considerable room for improving treatment outcomes in T1D across all age groups, but especially for adolescents and young adults.
The T1D Exchange Biobank consists of thousands of biological samples and clinical, demographic, and study-derived information from individuals with T1D.
Learn how T1D Exchange Biobank resources are being put to use right now to help researchers better understand type 1 diabetes to improve care and outcomes.
Severe hypoglycemia can be a serious health risk as well as scary and upsetting -- not just for the person with T1D but for family and friends as well. T1D Exchange set out to study which factors might be associated with severe hypoglycemia (SH).
Two hundred participants took part in the study. Half of the participants had experienced an SH event in the past year (this group is referred to as "Cases") and the other half had not experienced an SH event in the past 3 years (this group is referred to as "Controls"). Both groups had similar HbA1c levels and mean glucose. They were also similar in terms of other factors such as depression, daily functioning, and diabetes numeracy (this is loosely defined as how skilled someone is at applying math skills to diabetes care).
People with recent SH:
Evidence based research such as this study will lead to better interventions for those experiencing SH events, such as continuous glucose monitoring (CGM) devices, and may pave the way for affordable access to these devices as well.
As part of our online community of over 14,000 people touched by T1D, you can answer Question of the Day, participate in real-time research, share experiences and learn from others. Go >>
Help science advance research and improve lives by providing valuable blood samples from people with T1D. Go >>